Par Drugs and Chemicals Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Par Drugs and Chemicals Limited generated cash of $202,489,000, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore $144,109,000.
Cash Flow
| 2016 | 65.27M | -1.69M | -54.6M |
|---|---|---|---|
| 2018 | 43.18M | -5.98M | -36.74M |
| 2020 | 76.91M | -14.57M | 11.14M |
| 2021 | 120.85M | 507.07K | 16.48M |
| 2023 | 133.77M | -73.38M | -24K |
| 2024 | 202.48M | -58.38M | 0 |
PAR.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 222.43M | 162.06M | 73.79M | 305.88K | 184K | 0 |
Operating activities | ||||||
Net income | 145.01M | 150.79M | 147.26M | 59.91M | 25.53M | 4.21M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 34.36M | 32.33M | 28.19M | 27.61M | 31.35M | 26.49M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 32.36M | 14.98M | -831K | -38.48M | -6.12M | 1.39M |
Inventories | 12.01M | -6.66M | -799.14K | 13.77M | -787K | -16.03M |
Accounts payable | 0 | -25.70M | 5.13M | 12.72M | -25.21M | 0 |
Cash generated by operating activities | 202.48M | 133.77M | 120.85M | 76.91M | 43.18M | 65.27M |
Investing activities | ||||||
Purchases Of Investments | -19K | 0 | -49.67M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -60.80M | -76.33M | -50.49M | -15.58M | -6.38M | -1.52M |
Acquisitions Net | 120K | 2M | 49.20M | 250K | 0 | 0 |
Cash generated by investing activities | -58.38M | -73.38M | 507.07K | -14.57M | -5.98M | -1.69M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 0 | 85.27M | 0 | 0 |
Payments for dividends | 0 | 0 | -7.69M | -9.27M | -575 | -1K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -2.27M | -57.31M | -14.89M | -50.90M |
Cash used in financing activities | 0 | -24K | 16.48M | 11.14M | -36.74M | -54.6M |
Net Change In Cash | 144.10M | 60.36M | 137.84M | 73.48M | 454K | 9.29M |
Cash at end of period | 366.53M | 222.43M | 211.63M | 73.79M | 638K | 9.29M |
| Data source | Data source | Data source | Data source | Data source | Data source |